Emcure Pharmaceuticals Ltd Analyst Rating
based on 3 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 3 analysts offering long term price targets for Emcure Pharmaceuticals Ltd. An average target of ₹1663.33
Source: S&P Global Market Intelligence
Emcure Pharmaceuticals Ltd Share analysis
Emcure Pharmaceuticals Ltd price forecast by 3 analysts
Upside of42.00%
High
₹1730
Target
₹1663.33
Low
₹1580
Emcure Pharmaceuticals Ltd target price ₹1663.33, a slight upside of 42% compared to current price of ₹1206.55. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Emcure Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Emcure Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Emcure Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹1,171.55Day's Price Range₹1,220.852 Week's Low
52 Week's High
₹1,171.5552-Week Price Range₹1,580
| Returns % | |
| 1 Month Return | -19.67 % |
| 3 Month Return | -16.83 % |
| 1 Year Return | -13.82 % |
| Market Stats | |
| Previous Close | ₹1,171.35 |
| Open | ₹1,176.00 |
| Volume | 85.61K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹22,189.10Cr |
Emcure Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 38.03 |
| PEG Ratio | 2.39 |
| Market Cap | ₹22,189.10 Cr |
| P/B Ratio | 0 |
| EPS | 0 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 8.52 |
Emcure Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹22,189.10 Cr | -2.76% | 0.73 | ₹527 Cr | ₹6,658 Cr | |
| BUY | ₹14,131.10 Cr | 10.81% | 0.51 | NA | NA | |
| NA | ₹26.27 Cr | 24.45% | 0.50 | NA | NA | |
| NA | ₹156.89 Cr | 157.98% | 0.50 | ₹9 Cr | ₹188 Cr | |
| NA | ₹23.92 Cr | 99.6% | 1.86 | NA | NA |
Emcure Pharmaceuticals Ltd Mutual Fund Holdings
About Emcure Pharmaceuticals Ltd
Share Price: ₹1206.55 per share as on 29 Jan, 2025 04:01 PM
Market Capitalisation: ₹22,189.10Cr as of today
Revenue: ₹2,001.98Cr as on September 2024 (Q3 24)
Net Profit: ₹201.55Cr as on September 2024 (Q3 24)
Listing date: 10 Jul, 2024
| Organisation | Emcure Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Emcure Pharmaceuticals Ltd
Emcure Pharma Opens Largest R&D Centre in Gujarat - 23 Jan, 2025
Emcure Pharmaceuticals inaugurated its largest R&D facility in Ahmedabad, focusing on complex drug delivery systems. Over 300 scientists will work there, enhancing drug formulations and bioavailability. The company emphasizes its commitment to innovation and reduced reliance on the U.S. market.
Insights on Emcure Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 2.91% to 3.05% in Dec 2024 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 15.05% to 15.14% in Dec 2024 quarter
NEGATIVE IMPACTPrice Dip
In the last 7 days, EMCURE stock has moved down by -13.3%
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 3.30% to 3.10% in Dec 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 78.08% to 77.94% in Dec 2024 quarter
Emcure Pharmaceuticals Ltd Financials
Index Inclusions
Emcure Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 77.94% | ||
| Foreign Institutions | 3.05% | 4.85 | |
| Mutual Funds | 3.1% | ||
| Retail Investors | 15.14% | 0.61 | |
| Others | 0.77% | 16.61 |
Emcure Pharmaceuticals Ltd Key Indicators
Emcure Pharmaceuticals Ltd Valuation
Emcure Pharmaceuticals Ltd in the last 5 years
Lowest (38.03x)
January 28, 2025
Today (38.03x)
January 28, 2025
Industry (53.05x)
January 28, 2025
Highest (54.00x)
September 18, 2024
Emcure Pharmaceuticals Ltd Earnings and Dividends
Emcure Pharmaceuticals Ltd Earnings Results
Emcure Pharmaceuticals Ltd’s net profit jumped 39.83% since last year same period to ₹194.57Cr in the Q2 2024-2025. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 35.04% jump in its net profits since last 3-months.
Read More about Earnings Results
Emcure Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Emcure Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Emcure Pharmaceuticals Ltd
What is Emcure Pharmaceuticals Ltd price today?
Emcure Pharmaceuticals Ltd share price today stands at ₹1206.55, Open: ₹1176, Previous Close: ₹1171.35, High: ₹1220.8, Low: ₹1171.55, 52 Week High: ₹1580, 52 Week Low: ₹1171.55.
How to Buy Emcure Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Emcure Pharmaceuticals Ltd shares
Is Emcure Pharmaceuticals Ltd listed on NSE?
Emcure Pharmaceuticals Ltd is listed on NSE
Is Emcure Pharmaceuticals Ltd listed on BSE?
Emcure Pharmaceuticals Ltd is listed on BSE
What are today's High and Low prices of Emcure Pharmaceuticals Ltd?
- Today's highest price of Emcure Pharmaceuticals Ltd is ₹1220.8.
- Today's lowest price of Emcure Pharmaceuticals Ltd is ₹1171.55.
What are today's traded volumes of Emcure Pharmaceuticals Ltd?
Today's traded volume of Emcure Pharmaceuticals Ltd(EMCURE) is 85.61K.
What is today's market capitalisation of Emcure Pharmaceuticals Ltd?
Today's market capitalisation of Emcure Pharmaceuticals Ltd(EMCURE) is ₹22189.1Cr.
What is the 52 Week High and Low Range of Emcure Pharmaceuticals Ltd?
How much percentage Emcure Pharmaceuticals Ltd is down from its 52 Week High?
Emcure Pharmaceuticals Ltd (EMCURE) share price is ₹1206.55. It is down -23.64% from its 52 Week High price of ₹1580
How much percentage Emcure Pharmaceuticals Ltd is up from its 52 Week low?
Emcure Pharmaceuticals Ltd (EMCURE) share price is ₹1206.55. It is up 2.99% from its 52 Week Low price of ₹1171.55
What are the historical returns of Emcure Pharmaceuticals Ltd?
What is the PE ratio of Emcure Pharmaceuticals Ltd today?
PE Ratio of Emcure Pharmaceuticals Ltd is 38.03
PE ratio = Emcure Pharmaceuticals Ltd Market price per share / Emcure Pharmaceuticals Ltd Earnings per share